@pmarca 8 years ago
RT @MichaelMandel: Japan leaps ahead in regenerative medicine, with faster approval process based on safety and probable efficacy http://www.japantimes.co.jp/news/2015/09/03/national/science-health/regenerative-medicine-get-boost-deregulation-japan/#.VfX5uWSqqko @PPI
@techcrunch.com 9 years ago
Amid ‘Right To Try’ Debate, myTomorrows Raises €4.5M To Give Patients Access To Development-Stage Drugs